M4i researchers Dr. Berta Cillero Pastor and Prof. Maarten Honing participate in DARTBAC project
Dr. Berta Cillero Pastor and Prof. Maarten Honing will spend the next 6 years developing new mass spectrometry (imaging) and SPR based solutions to address the explosively growing problem of antimicrobial resistance (AMR) in orthopedic implants.
As part of the National Science Agenda, NWO is providing a grant of 9.8 million euros to the DARTBAC project led by Dr. Chris Arts (MUMC+): Dutch Antimicrobial Resistance Technology development and Biofilm Assessment Consortium.
The team will study how bacteria grow on implant surfaces, to ultimately design materials which will drastically reduce undesired infections to take place.
For more information please visit: https://nwa-dartbac.nl
Also read:
-
When the most unknown organ must be removed
Friday, September 16, 2022Read moreAn organ that disappears almost completely after puberty, but in rare cases can regrow in size and even harbor a tumor: the thymus, also known as the thymus. Physician-researcher Florit Marcuse, affiliated with Maastricht University's Faculty of Health Medicine and Life Sciences, examined this relatively unknown organ and found that care for these patients could be further improved, both in the Netherlands and abroad.
-
Repeat miscarriages: does the immune system play a role?
Thursday, September 15, 2022Read moreIn women trying to conceive, 1-3% experience repeated miscarriages. For more than 50% of these women, a cause for the miscarriages has yet to be found. New research from Maastricht University (UM) and the Maastricht University Medical Centre+ (MUMC+) shows that the immune system’s Natural Killer (NK) cells may be involved. In women with repeated miscarriages, the NK cells have different characteristics.
-
New European project aims to think outside the box when it comes to medicine
Monday, September 5, 2022Read moreThe European Commission has awarded €23 million to set up a new platform for drug repurposing: the use of existing drugs in diseases other than those for which they were originally developed. In the next seven years UM will develop the platform REPO4EU (precision drug REPurpOsing for Europe) together with various international partners. A congress in Maastricht held on 2-3 September kicked off the project.
Facebook
Twitter
LinkedIn
Forward
Reddit